Eurazeo / 2018 Registration document

COMPANY FINANCIAL STATEMENTS Notes to the Company financial statements

CASH AND CASH EQUIVALENTS NOTE 4

Gross value 12/31/2017

Gross value 12/31/2018

Valuation at 12/31/2018

Additions

Disposals

(In thousands of euros) Treasury instruments

6,947 14,970

36,691

(41,404)

2,234 14,985

2,231

Listed bonds

15

14,985

Currency hedges

215

94

(215)

94

94

Marketable securities

22,132 19,957 341,386 362,186 86,786 471,104 843

36,800 123,136 286,255 410,052 34,290 481,142 661

(41,619) (19,957) (341,386) (362,186) (25,473) (429,277) (843)

17,313 123,136 286,255 410,052 95,604 522,969 661

17,311

Bank accounts and cash in hand

123,136 286,255

Term accounts

Interest on term accounts Cash and cash equivalents

661

410,052 93,930 521,293

Treasury shares

TOTAL

The Company mainly invests its cash balances in negotiable debt instruments, money-market funds and interest-bearing term accounts.

Treasury shares (shares earmarked for grant to employees) “Treasury shares” consist of 1,954,721 Eurazeo shares, representing 2.6% of the share capital. These shares are held for presentation under certain stock option plans and employee free share plans. They have been allocated in accordance with ANC Regulation 2014-03 at net value and break down as follows:

Treasury shares earmarked for grant to employees

Number of shares 1,954,721 1,954,721

Cost price per share Total gross value

Impairment

Net value

(In thousands of euros as of 12/31/2018) Shares allocated to specific plans •

48.91

95,604 95,604

1,674 (1) 1,674

93,930

TOTAL 93,930 The impairment was recognized on the transfer of shares from the account “Shares not allocated to specific plans” to the account “Shares allocated to specific (1) plans”.

During 2018, a non-recurring gain of €12,270 thousand was generated on the exercise of share purchase options and a loss of €832 thousand was recognized on the exercise of share purchase options, based on the historical cost price of shares (See Note 15).

The loss was offset by a provision reversal of €1,137 thousand. A charge net of reversals to liability provisions of €12,087 thousand was recognized in 2018 in respect of shares allocated to specific plans.

5

Eurazeo

307

2018 Registration Document